Holen Sie sich die Stockscreener-App
13.87
3.75%
-0.54
Handel nachbörslich:
13.87
Schlusskurs vom Vortag:
$14.41
Offen:
$14.32
24-Stunden-Volumen:
1.86M
Relative Volume:
0.87
Marktkapitalisierung:
$1.82B
Einnahmen:
$3.34B
Nettoeinkommen (Verlust:
$97.10M
KGV:
-23.31
EPS:
-0.595
Netto-Cashflow:
$208.00M
1W Leistung:
-4.74%
1M Leistung:
-0.14%
6M Leistung:
+16.36%
1J Leistung:
-35.91%
1-Tages-Spanne:
$13.86
$14.42
1-Wochen-Bereich:
$13.86
$14.78
52-Wochen-Spanne:
$11.41
$23.44
Surgery Partners Inc Stock (SGRY) Company Profile
Firmenname
Surgery Partners Inc
Sektor
Branche
Telefon
615-234-5900
Adresse
340 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY vs HCA, THC, EHC, FMS, DVA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
13.87 | 1.89B | 3.34B | 97.10M | 208.00M | -0.595 |
HCA
Hca Healthcare Inc
|
426.74 | 94.31B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
255.56 | 20.91B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
121.49 | 12.18B | 6.07B | 793.80M | 464.40M | 5.9914 |
FMS
Fresenius Medical Care Ag Adr
|
22.38 | 12.08B | 22.44B | 1.35B | 2.03B | 1.9002 |
DVA
Davita Inc
|
174.92 | 11.39B | 13.84B | 1.10B | 1.49B | 10.42 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Fortgesetzt | JP Morgan | Neutral |
| 2025-07-28 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-16 | Eingeleitet | BofA Securities | Buy |
| 2024-10-14 | Eingeleitet | UBS | Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-06-28 | Eingeleitet | Macquarie | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-11-14 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-06-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-05-12 | Eingeleitet | Mizuho | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-11-23 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-06-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-11-30 | Eingeleitet | Barclays | Overweight |
| 2021-11-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-11-01 | Eingeleitet | JP Morgan | Neutral |
| 2021-10-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-06-23 | Fortgesetzt | Stifel | Hold |
| 2020-09-17 | Bestätigt | The Benchmark Company | Buy |
| 2020-04-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-03-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-01-14 | Bestätigt | The Benchmark Company | Buy |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-09-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-06-28 | Hochstufung | Stifel | Sell → Hold |
| 2018-01-30 | Bestätigt | The Benchmark Company | Buy |
| 2017-11-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-08-09 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-08-09 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2017-08-09 | Herabstufung | Stifel | Hold → Sell |
| 2017-04-24 | Bestätigt | Stifel | Hold |
| 2017-03-10 | Herabstufung | Stifel | Buy → Hold |
| 2017-01-31 | Eingeleitet | The Benchmark Company | Buy |
| 2016-06-10 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-03-14 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-10-27 | Eingeleitet | Stifel | Buy |
| 2015-10-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-10-26 | Eingeleitet | Raymond James | Strong Buy |
Alle ansehen
Surgery Partners Inc Aktie (SGRY) Neueste Nachrichten
Wall Street Analysts See a 26.14% Upside in Surgery Partners (SGRY): Can the Stock Really Move This High? - Eastern Progress
A Look at Surgery Partners Inc (SGRY) After 7.8% Decline -- GF V - GuruFocus
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know - Yahoo Finance
Behavioral Patterns of SGRY and Institutional Flows - Stock Traders Daily
Surgery Partners (SGRY): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Surgery Partners: A 'Buy' After Idaho Falls Asset Divestment (NASDAQ:SGRY) - Seeking Alpha
Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock? - Yahoo Finance
Surgery Partners closes $800 million deal for Idaho hospitals - The Business Journals
Surgery Partners (SGRY) Resets 2026 Outlook On Facility Removal As Valuation Questions Build - simplywall.st
Analysts Offer Insights on Healthcare Companies: Surgery Partners (SGRY), Envista Holdings (NVST) and Inventiva (IVA) - The Globe and Mail
SGRY Reiterated by TD Cowen -- Price Target Maintained at $19 - GuruFocus
BofA Securities Maintains Surgery Partners(SGRY.US) With Buy Rating, Raises Target Price to $20 - Moomoo
Surgery Partners Inc (SGRY) Shares Fall 4.2% -- What GF Score of 61 Tells Investors - GuruFocus
Surgery Partners completes sale of Idaho Falls facilities for $797m - Investing.com Nigeria
Intermountain closes $797M hospital deal with Surgery Partners - Modern Healthcare
Surgery Partners Lowers 2026 Revenue Guidance; Completes $797 Million Sale of Idaho Falls Facilities - Yahoo Finance
Surgery Partners,Pro Forma Full-Year 2026 - Moomoo
Surgery Partners (SGRY) exits Idaho Falls hospitals to cut debt - Stock Titan
Surgery Partners gets $587M cash as Intermountain buys Idaho hospitals - Stock Titan
Surgery Partners Inc. (SGRY) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Surgery Partners Is Maintained at Neutral by JP Morgan - Moomoo
J.P. Morgan Maintains Surgery Partners(SGRY.US) With Hold Rating, Raises Target Price to $15 - Moomoo
Intermountain Health Care, Inc. completed the acquisition of remaining majority stake in Mountain View Hospital LLC from Surgery Partners, Inc.. - marketscreener.com
Avoiding Lag: Real-Time Signals in (SGRY) Movement - Stock Traders Daily
Surgery Partners Inc. (SGRY) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Surgery Partners Director Teresa DeLuca Buys 11,250 Shares - Yahoo Finance
Surgery Partners Inc (SGRY) Stock Down 4.2% -- Now Undervalued? GF Score: 61/100 - GuruFocus
How Surgery Partners Inc. (SGRY) Affects Rotational Strategy Timing - Stock Traders Daily
Surgery Partners stock gains as investors digest recent rally - AD HOC NEWS
Surgery Partners stock holds gains as investors await next earnings update - ad-hoc-news.de
Barclays Maintains Surgery Partners(SGRY.US) With Hold Rating, Maintains Target Price $14 - moomoo.com
How Mixed Q2 Results and Slower M&A At Surgery Partners (SGRY) Have Changed Its Investment Story - simplywall.st
Surgery Partners Inc (SGRY) Stock Up 4.2% and Still Undervalued -- GF Score: 63/100 - GuruFocus
Surgery Partners director Teresa DeLuca buys $161,212 in stock By Investing.com - Investing.com Nigeria
Surgery (SGRY) EPS and Revenue: EPS Lands Above Forecast; After Earnings: Shares Move Higher 2.50% on the DayEarnings Stability Report - Vinanet
Surgery Partners director Teresa DeLuca buys $161,212 in stock - Investing.com
Surgery Partners (SGRY) Insider Teresa Deluca Purchases 10,000 S - GuruFocus
Surgery Partners (SGRY) Stock May Be Undervalued After Q2 Earnings Beat - Yahoo Finance
Surgery Partners Director Teresa DeLuca Acquires 10,000 Shares at $14.35 Each - Kalkine Media
Surgery Partners Earnings Call Highlights Strategic Reset - TipRanks
Does Surgery Partners’ (SGRY) Slower M&A Pace Clarify or Complicate Its ASC-Focused Strategy? - Sahm
Surgery Partners Beats Q2 Estimates, Divests Idaho Falls Hospitals in Strategic Pivot - finance.biggo.com
Surgery Partners (SGRY) Q2 2026 Earnings Call Transcript - The Globe and Mail
Community Health Trades at a Deep Discount to Peers: Hold or Fold? - TradingView
The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call - Yahoo Finance
Surgery Partners (SGRY) Reaffirmed Guidance On Revenue Growth, Is It Still A Bargain? - Sahm
Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY) - Yahoo Finance
RBC Capital Adjusts Price Target on Surgery Partners to $19 From $20, Keeps Outperform Rating - Moomoo
Surgery Partners Inc. (SGRY) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
King Street Capital discloses 4.6% Surgery Partners (SGRY) holding in Schedule 13G - Stock Titan
Why (SGRY) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Finanzdaten der Surgery Partners Inc-Aktie (SGRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Surgery Partners Inc-Aktie (SGRY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Burkhalter Danielle | Chief Human Resources Officer |
Mar 13 '26 |
Sale |
12.83 |
3,469 |
44,507 |
76,864 |
| Brittenham Marissa | Chief Strategy Officer |
Mar 13 '26 |
Sale |
12.54 |
3,657 |
45,859 |
94,196 |
| Doherty David T | Chief Financial Officer |
Mar 16 '26 |
Sale |
12.50 |
8,867 |
110,838 |
221,679 |
| Evans Jason Eric | Chief Executive Officer |
Mar 16 '26 |
Sale |
12.47 |
20,400 |
254,388 |
920,386 |
| Baldock Jennifer | Chief Admin & Dev Officer |
Mar 12 '26 |
Sale |
13.17 |
5,798 |
76,360 |
326,474 |
1.18%
1.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):